Jogender Tushir-Singh, Ph.D.
Associate Professor of Medical Microbiology and Immunology
To see if Jogender Tushir-Singh is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Research/Academic Interests
Dr. Tushir-Singh’s research focuses on generating protein therapeutics in the antibody engineering space. His lab brings several years of industrial and academic experience in antibody humanization, bispecific designs, and engineering antibody-peptide conjugates using IgG1 and smaller scFv-based formats.
The loss of his grandmother to ovarian cancer instilled in him a strong personal motivation to study this disease. This experience drives his interest in ovarian cancer cell signaling, death receptors (DR5 and Fas activation biology), CAR-T strategies, cancer immunology approaches, and targeted protein and peptide design. He is also interested in understanding the mechanisms behind the differential clinical response of T-cell-based immunotherapies in solid versus liquid tumors.
He leverages these insights to design the next generation of effective therapeutics against ovarian and other solid tumors.
Division
Gynecologic Oncology
Center/Program Affiliation
Undergraduate School
B.S., University of Delhi, 2001
Other School
Ph.D., Cell and Molecular, University of Notre Dame, 2007
Fellowship
Senior Scientist, Abbive Inc., 2012-14
Fellowship
Principal Scientist, Boehringer Ingelheim, 2014-15
Fellowship
Post Doc, Biochemistry and Molecular Genetics, University of Massachusetts Medical School, 2009-2012
Breast Cancer Research Breakthrough award by U.S Department of Defense (DoD) (2017),
Early Career Investigator Award, Ovarian Cancer Academy, U.S. DoD (2018),
Invited Plenary Speaker, Paris “Mobilizing T-cell to tumors, CAR-T and Bispecific Antibodies” (2019) Schiff Foundation award (2020),
Executive Vice President (EVP)'s Exceptional Research Contribution Award Merit List, University of Virginia School of Medicine (2021),